Interleukin 27 as a sepsis diagnostic biomarker in critically ill adults

Shock

Volumn 40, Issue 5, 2013, Pages 382-386

  Wong, Hector R ^a,b   Lindsell, Christopher J ^b   Lahni, Patrick ^a   Hart, Kimberly W ^b   Gibot, Sebastien ^c,d  

^a CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY HOSPITAL OF NANCY   (France)

^d UNIVERSITÉ DE LORRAINE   (France)

Author keywords

biomarkers; decision tree; diagnosis; interleukin 27; procalcitonin; Sepsis

Indexed keywords

INTERLEUKIN 27; PROCALCITONIN;

ADULT; ARTICLE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DECISION TREE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; HUMAN; LUNG INFECTION; MAJOR CLINICAL STUDY; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SECONDARY ANALYSIS; SEPSIS;

ADULT; BIOLOGICAL MARKERS; CALCITONIN; DECISION TREES; HUMANS; INTERLEUKIN-27; LUNG DISEASES; PREDICTIVE VALUE OF TESTS; PROTEIN PRECURSORS; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEPSIS;

EID: 84887054338     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3182a67632     Document Type: Article

References (26)

1. Marshall JC, Reinhart K: Biomarkers of sepsis. Crit Care Med 37(7): 2290-2298, 2009.
2. Kaplan JM, Wong HR: Biomarker discovery and development in pediatric critical care medicine. Pediatr Crit Care Med 12(2):165-173, 2011.
3. Standage SW, Wong HR: Biomarkers for pediatric sepsis and septic shock. Expert Rev Anti Infect Ther 9(1):71-79, 2011.
4. Tang BM, Eslick GD, Craig JC, McLean AS: Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 7(3):210-217, 2007.
5. Gibot S, Bene MC, Noel R, Massin F, Guy J, Cravoisy A, Barraud D, De Carvalho Bittencourt M, Quenot JP, Bollaert PE, et al.: Combination biomark-ers to diagnose sepsis in the critically ill patient. Am J Respir Crit Care Med 186(1):65-71, 2012.
6. Wang HJ, Zhang PJ, Chen WJ, Jie D, Dan F, Jia YH, Xie LX: Characterization and Identification of novel serum microRNAs in sepsis patients with different outcomes. Shock 39(6):480-487, 2013.
7. Rivers EP, Jaehne AK, Nguyen HB, Papamatheakis DG, Singer D, Yang JJ, Brown S, Klausner H: Early biomarker activity in severe sepsis and septic shock and a contemporary review of immunotherapy trials: not a time to give up, but to give it earlier. Shock 39(2):127-137, 2013.
8. Monaghan SF, Thakkar RK, Tran ML, Huang X, Cioffi WG, Ayala A, Heffernan DS: Programmed death 1 expression as a marker for immune and physiological dysfunction in the critically ill surgical patient. Shock 38(2): 117-122, 2012.
9. Wong HR, Cvijanovich NZ, Hall M, Allen GL, Thomas NJ, Freishtat RJ, Anas N, Meyer K, Checchia PA, Lin R, et al.: Interleukin-27 is a novel candidate diagnostic biomarker for bacterial infection in critically ill children. Crit Care 16(5):R213, 2012.
10. Scicluna BP, van der Poll T: Interleukin-27: a potential new sepsis biomarker exposed through genome-wide transcriptional profiling. Crit Care 16(6):188, 2012.
11. Wojno ED, Hunter CA: New directions in the basic and translational biology of interleukin-27. Trends Immunol 33(2):91-97, 2012.
12. Pflanz S, Timans JC, Cheung J, Rosales R, Kanzler H, Gilbert J, Hibbert L, Churakova T, Travis M, Vaisberg E, et al.: IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 16(6):779-790, 2002.
13. Villarino AV, Larkin J 3rd, Saris CJ, Caton AJ, Lucas S, Wong T, de Sauvage FJ, Hunter CA: Positive and negative regulation of the IL-27 receptor during lymphoid cell activation. J Immunol 174(12):7684-7691, 2005.
14. Wirtz S, Tubbe I, Galle PR, Schild HJ, Birkenbach M, Blumberg RS, Neurath MF: Protection from lethal septic peritonitis by neutralizing the biological function of interleukin 27. J Exp Med 203(8):1875-1881, 2006.
15. Schuetz P, Albrich W, Mueller B: Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future. BMC Med 9:107, 2011.
16. Muller R, Mockel M: Logistic regression and CART in the analysis of mul-timarker studies. Clin Chim Acta 394(1-2):1-6, 2008.
17. Wong HR, Salibury S, Xiao Q, Cvijanovich NZ, Hall M, Allen GL, Thomas NJ, Freishtat RJ, Anas N, Meyer K, et al.: The pediatric sepsis biomarker risk model. Crit Care 16(5):R174, 2012.
18. VassarStats: Web site for Statistical Computation. Available at: http://faculty. vassar.edu/lowry/VassarStats.html. Accessed June 1, 2013.
19. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS: Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27(2):157-172; discussion 207-212, 2008.
20. Hilden J, Gerds TA: A note on the evaluation of novel biomarkers: do not rely on integrated discrimination improvement and net reclassification index [published online ahead of print]. Stat Med 2013. 2013 Apr 2. [Epub ahead of print] doi: 10.1002/sim.5804.
21. Wynn J, Cornell TT, Wong HR, Shanley TP, Wheeler DS: The host response to sepsis and developmental impact. Pediatrics 125(5):1031-1041, 2010.
22. Wynn JL, Wong HR: Pathophysiology and treatment of septic shock in neo-nates. Clin Perinatol 37(2):439-479, 2010.
23. Wynn JL, Cvijanovich NZ, Allen GL, Thomas NJ, Freishtat RJ, Anas N, Meyer K, Checchia PA, Lin R, Shanley TP, et al.: The influence of developmental age on the early transcriptomic response of children with septic shock. Mol Med 17(11-12):1146-1156, 2011.
24. Wynn JL, Scumpia PO, Winfield RD, Delano MJ, Kelly-Scumpia K, Barker T, Ungaro R, Levy O, Moldawer LL: Defective innate immunity predisposes murine neonates to poor sepsis outcome but is reversed by TLR agonists. Blood 112(5):1750-1758, 2008.
25. Wong HR, Shanley TP, Sakthivel B, Cvijanovich N, Lin R, Allen GL, Thomas NJ, Doctor A, Kalyanaraman M, Tofil NM, et al.: Genome-level expression profiles in pediatric septic shock indicate a role for altered zinc homeostasis in poor outcome. Physiol Genomics 30(2):146-155, 2007.
26. Wong HR, Cvijanovich N, Allen GL, Lin R, Anas N, Meyer K, Freishtat RJ, Monaco M, Odoms K, Sakthivel B, et al.: Genomic expression profiling across the pediatric systemic inflammatory response syndrome, sepsis, and septic shock spectrum. Crit Care Med 37(5):1558-1566, 2009.